Supravalvular aortic stenosis (SVAS) is a rare but serious heart condition that affects the aorta, the main artery that carries blood from the heart to the rest of the body. In this condition, there is a narrowing or constriction in the aorta just above the aortic valve, which can interfere with blood flow to the body's organs and tissues.
SVAS is typically diagnosed in infancy or childhood, but can
also be found in adults. The condition can be inherited in an autosomal
dominant manner or can arise spontaneously due to a mutation in the elastin
gene.
In this article, we will discuss the causes, symptoms,
diagnosis, treatment, and outlook for individuals with SVAS.
Causes of Supravalvular Aortic Stenosis:
The exact cause of SVAS is not known, but it is believed to
be due to a problem with the elastin gene. Elastin is a protein that helps give
the aorta its elasticity and flexibility. A mutation in the elastin gene can
cause the aorta to become stiff and less flexible, leading to the narrowing of
the aorta seen in SVAS.
In some cases, SVAS may be associated with other genetic
syndromes, such as Williams syndrome or Noonan syndrome.
Symptoms of Supravalvular Aortic Stenosis:
The symptoms of SVAS can vary depending on the severity of
the narrowing in the aorta. In mild cases, there may be no symptoms at all,
while in more severe cases, symptoms may include:
- Shortness of breath, especially with exertion
- Chest pain or discomfort
- Fainting or dizziness
- Fatigue or weakness
- Heart palpitations or an irregular heartbeat
- High blood pressure
- Developmental delays or learning disabilities (in cases associated with genetic syndromes)
Diagnosis of Supravalvular Aortic Stenosis:
SVAS may be suspected based on a child's symptoms or on
findings from a routine physical exam. The diagnosis is typically confirmed
using imaging tests such as echocardiography or cardiac MRI. These tests can
show the narrowing in the aorta and any other associated heart defects.
In some cases, genetic testing may be recommended to look
for mutations in the elastin gene or other associated genetic syndromes.
Treatment of Supravalvular Aortic Stenosis:
The treatment for SVAS depends on the severity of the
condition. Mild cases may not require any treatment at all, while more severe
cases may require surgery to repair or replace the narrowed portion of the
aorta.
In some cases, a procedure called balloon angioplasty may be
used to widen the narrowed area of the aorta. This involves threading a small
balloon-tipped catheter through a blood vessel and into the narrowed portion of
the aorta. The balloon is then inflated to widen the narrowed area.
In severe cases of SVAS, surgery may be needed to remove the
narrowed portion of the aorta and replace it with a graft or a piece of the
patient's own blood vessel. This type of surgery is called an aortic arch
reconstruction.
Outlook for Individuals with Supravalvular Aortic Stenosis:
The outlook for individuals with SVAS depends on the
severity of the condition and whether any other associated heart defects are
present. In mild cases, individuals may lead normal, healthy lives with little
or no treatment.
In more severe cases, surgery may be required to correct the
narrowing in the aorta. With proper treatment, most individuals with SVAS can
expect to live a normal lifespan.
It is important for individuals with SVAS to receive regular
follow-up care with a cardiologist to monitor their heart health and ensure
that any associated heart defects are properly managed. Additionally, genetic
counseling may be recommended
